Participants were randomly assigned to receive once-weekly subcutaneous doses of tirzepatide (5 mg, 10 mg, or 15 mg) or a placebo for 72 weeks
Brushing your teeth is safe and encouraged
For patients whose symptoms significantly impact quality of life, healthcare providers may consider evidence-based pharmacologic options such as certain SSRIs/SNRIs, gabapentin, oxybutynin, or fezolinetant (FDA-approved for moderate to severe vasomotor symptoms)
Behavioral approachesmeal planning, structured exercise programs, and behavioral supportcarry no direct risk to milk supply or infant health when implemented sensibly
Kohrt recommends women get a bone density scan before starting a GLP-1, especially since current screening guidelines don't recommend routine osteoporosis checks until age 65, which she says may be too late given how many younger women are now on the drugs
O.RiveraE